Compare IDT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDT | PLSE |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 3.6B |
| IPO Year | 1996 | 2015 |
| Metric | IDT | PLSE |
|---|---|---|
| Price | $70.39 | $52.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $80.00 | $22.00 |
| AVG Volume (30 Days) | 126.8K | ★ 531.6K |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | ★ 18.50 | N/A |
| EPS | ★ 2.59 | N/A |
| Revenue | ★ $1,231,495,000.00 | N/A |
| Revenue This Year | $4.34 | $840.00 |
| Revenue Next Year | N/A | $287.54 |
| P/E Ratio | $26.24 | ★ N/A |
| Revenue Growth | ★ 2.13 | N/A |
| 52 Week Low | $45.72 | $12.56 |
| 52 Week High | $70.00 | $58.90 |
| Indicator | IDT | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 62.75 | 67.23 |
| Support Level | $50.95 | $24.27 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.71 | 3.85 |
| MACD | -0.18 | -0.21 |
| Stochastic Oscillator | 86.19 | 63.42 |
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.